あなたの病院での多剤耐性グラム陰性桿菌の制御について:変革への旅

2015.04.29

Controlling multidrug-resistant Gram-negative bacilli in your hospital: a transformational journey


L.S. Munoz-Price*
*Medical College of Wisconsin, WI, USA
Journal of Hospital Infection (2015) 89, 254-258
世界では過去 20 年間に多剤耐性グラム陰性菌が増大している。本稿では、カルバペネム耐性アシネトバクター・バウマニー(Acinetobacter baumannii)の制御を目的とした介入バンドルの実施、および効果的な制御に必要となる文化の変革に関して、著者の個人的な経験を述べる。
サマリー原文(英語)はこちら

同カテゴリの記事

2015.05.31

Investigating the impact of clinical anaesthetic practice on bacterial contamination of intravenous fluids and drugs

2015.06.30

Detection and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae in high-risk patients in an Irish tertiary care hospital

2014.01.30

Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital

2020.10.30

Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople)
B. Carter*, J.T. Collins, F. Barlow-Pay, F. Rickard, E. Bruce, A. Verduri, T.J. Quinn, E. Mitchell, A. Price, A. Vilches-Moraga, M.J. Stechman, R. Short, A. Einarsson, P. Braude, S. Moug, P.K. Myint, J. Hewitt, L. Pearce, K. McCarthy, on behalf of the COPE Study Collaborators
*King’s College London, UK
Journal of Hospital Infection (2020) 106, 376-384

2018.09.25

Proton pump inhibitor use as a risk factor for Enterobacteriaceal infection: a case-control study